Seeking Alpha

Frankie62 » Comments » MTXX

  • 3 Reasons Not to Predict FDA Action: Matrixx, Savient, Dendreon  [View article]
    In addition DNDN has a similar treatment for breast cancer - Neuvenge which is in trials. The "packet" technology could have other applications as well. Manufacturing facilities are being prepared in NJ and GA as well as the Seattle location. Final BLA to be filed in Q4.
    Aug 19 11:35 am |Rating: +1 0 |Link to Comment
More on MTXX by Frankie62
Comments by Ticker
Frankie62's
Comments Stats
23 comments
Rating: 15 (15 - 0 )